A new technology to improve DNA and RNA testing methods
A probe-based higher order multiplex technology to expand the capacity of digital PCR systems
This study is working on a new testing method that can quickly check for several DNA or RNA markers at once, making it easier and cheaper for labs to provide accurate diagnoses for conditions like acute lymphoblastic leukemia, which could help patients get the care they need faster.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kasa Bio, L.l.c. NIH-funded |
| Lab location | 1 site (Peachtree Corners, UNITED STATES) |
| Project ID | NIH-11183168 on NIH RePORTER |
What this research studies
This research focuses on developing a novel multiplexing technology for digital PCR systems, which allows for the simultaneous detection of multiple DNA or RNA biomarkers. By enhancing the capacity and reducing costs associated with current digital PCR methods, this approach aims to make testing more accessible and efficient for clinical laboratories. The technology seeks to minimize the amount of clinical samples needed and reduce environmental waste, making it a more sustainable option for biomarker quantification. Patients may benefit from more accurate and timely diagnoses of conditions like acute lymphoblastic leukemia through improved testing methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute lymphoblastic leukemia or other conditions requiring precise biomarker quantification.
Not a fit: Patients with conditions that do not involve DNA or RNA biomarker testing may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and cost-effective testing for various cancers, improving patient outcomes.
How similar studies have performed: Other research has shown promise in enhancing digital PCR technologies, indicating that this approach could lead to significant advancements in biomarker testing.
Where this research is happening
Peachtree Corners, UNITED STATES
- Kasa Bio, L.l.c. — Peachtree Corners, United States (Active)
Researchers
- Principal investigator: Madanahally Divakar, Kiran — Kasa Bio, L.l.c.
- Study coordinator: Madanahally Divakar, Kiran
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.